Pfizer's Earnings Made Easy

Mid-summer is considered prime beach season, but investors know more importantly -- it is second-quarter earnings season.

With that in mind, this episode of The Motley Fool's Market Checkup is dedicated to heavy hitters in the pharmaceutical industry. Watch and find out how the second-quarter results of four big pharma stocks stack up, and what challenges and opportunities lie ahead for them.

In this video, health-care analysts David Williamson and Max Macaluso drill down on Pfizer's recent results, detailing everything investors need to know, including what the dramatic reorganization means for the company's future.

Rising health-care costs continue to be a hotly debated topic, and even legendary investor Warren Buffett called this trend "the tapeworm that's eating at American competitiveness." To learn more about what's happening to the health-care system -- and how to potentially profit from this trend -- click here for free, immediate access.

Follow David on Twitter: @MotleyDavid.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2589458, ~/Articles/ArticleHandler.aspx, 4/18/2014 6:03:04 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement